2018 San Antonio Breast Cancer Symposium Coverage

Save as Favorite
Sign in to receive recommendations (Learn more)
SABCS 2018

Every December, the San Antonio Breast Cancer Symposium brings together clinicians, researchers, and advocates to discuss the latest breast cancer study results. We’re proud to present our coverage below.







Research News

Low-Dose Tamoxifen May Be an Option to Reduce Risk of Recurrence, Invasive Disease After Non-Invasive Breast Cancer

Delaying Chemotherapy More Than 30 Days Linked to Worse Outcomes for Triple-Negative Breast Cancer

New Analysis Shows Immunotherapy Tecentriq Only Effective in PD-L1-Positive Breast Cancer

Kadcyla Seems Better Than Herceptin for Early-Stage, HER2-Positive Residual Breast Cancer

Podcasts

Longer Time to Chemotherapy Linked to Worse Outcomes in Triple-Negative Disease
Zaida Morante, M.D.

Surgery Choice Seems to Affect Quality of Life for Younger Women
Laura Dominici, M.D., FACS

Oxybutynin to Ease Hot Flashes
Roberto Leon-Ferre, M.D.

Caregiving for a Person With Metastatic Breast Cancer
Tim Watkins

I Was A 24-Year-Old Man With Breast Cancer -- Heard in the Halls: Voices From the 2018 San Antonio Breast Cancer Symposium
Bret Miller

Metastatic Breast Cancer Alliance and SHARE Cancer Support Projects -- Heard in the Halls: Voices From the 2018 SABCS
Christine Benjamin

The Elements Project -- Heard in the Halls: Voices From the 2018 San Antonio Breast Cancer Symposium
Beth Fairchild

Research for Young Survivors -- Heard in the Halls: Voices From the 2018 San Antonio Breast Cancer Symposium
Kelly Owens, Ph.D.

SABCS Through the Eyes of a Person With Metastatic Disease -- Heard in the Halls: Voices From the 2018 SABCS
Shirley Mertz

Verzenio Side Effects: What Patients Are Reporting
Matthew Goetz, M.D.

2018 SABCS Preview -- Heard in the Halls: Voices From the 2018 San Antonio Breast Cancer Symposium
Maura Dickler, M.D.


Was this article helpful? Yes / No

Eoy18 sidebar 1
Back to Top